12/21/07 Jim Cramer's "Mad Money"
Cramer admitted he made a mistake when he named Rite Aid (RAD) as one of his speculation stocks of the year. He also added though, hat when he saw it wasn't working, he got out. RAD's CEO Mary Sammons joined Cramer on the show. Cramer says the fact that she's not ducking out now, shows great character, after the bad quarter. Sammons says Rite Aid is early on in the process of absorbing the Brooks and Eckerd acquisitions, that they are a good thing for the company, and the long-term integration is going to be good. Sammons said the company expects its sales to improve as it completes its integration. She emphasized that RAD is a long-term story and shareholders will eventually be rewarded. Cramer said let the viewers decide themselves whether to get in RAD. Recently, Cramer said he came across two stocks he wasn't too familiar with: Moog (MOGA) and Hill Int'l (HINT). On MOOG there is lack of visibility in the industrial division (46% of sales), and the medical sector is only 4% of the business. Cramer is hesitant to endorse MOOG. A better play would be Raytheon (RTN) and Eaton (ETN). On HILL, Cramer liked that it had $100M in cash, good international exposure and through acquisitions it could move from 17th largest in the sector to 12th. No analyst coverage as of yet in the name. At this point Cramer would rather own Foster Wheeler (FWLT) or Shaw Group (SGR). SELL BLOCK: GS (grossly misunderstood, don't group with other banks - now he is recommending it). Cramer talked with the CEO of Medco Health (MHS). He said it's an easy call for him, that MHS is a high-visibility company that is not dependent on whether or not the Fed gets it right. It is a buy. LIGHTENING ROUND: (Bullish) SNCR; MON; DD; ACN; HRS; AUY; EBAY. (Bearish) PDCO; COH; SVVS; SIL.
News 
Market Data 
Discover 
AI
